Viral Pharyngitis Follow-up
- Author: KoKo Aung, MD, MPH, FACP; Chief Editor: Michael Stuart Bronze, MD more...
Washing hands frequently, using disposable tissues, and limiting human contact are important preventive measures for the common cold syndrome and other viral pharyngitis. No consistent benefit was demonstrated in preventing a common cold with large doses of vitamin C.
Live adenovirus vaccines have been successfully used in military populations but are not available for civilian use.
Administration of influenza vaccine to high-risk individuals and those who want to prevent influenza is the major preventive measure. Amantadine may be used to prevent influenza A during outbreaks.
The complication rate of viral pharyngitis associated with a common cold is quite low. Purulent bacterial otitis media and sinusitis may occur.
Infectious mononucleosis may be complicated by tonsillar and peritonsillar abscess, necrotic epiglottitis, airway obstruction, hepatic dysfunction, splenic rupture, hypersplenism, encephalitis, pneumonitis, pericarditis, and hematologic disorders.
Herpetic pharyngitis may lead to necrotizing tonsillitis, epiglottitis, and recurrent disease.
Influenza may be complicated by secondary bacterial pneumonia. Pneumococcal pneumonia is most common. Staphylococcal pneumonia is most serious.
RSV infection, particularly in infants, elderly persons, and patients with underlying COPD, may be complicated by pneumonia and respiratory failure.
Complications of HIV infection are beyond the scope of this article. For more information, see the article HIV Disease.
The prognosis of a patient with a common cold is excellent. Most adults recover in less than a week, and most children in less than 2 weeks.
In patients with infectious mononucleosis, fever disappears in approximately 10 days. Lymphadenopathy and splenomegaly disappear in approximately 4 weeks. Debility sometimes remains for approximately 2-3 months, and the condition is occasionally fatal because of splenic rupture, hypersplenism, or encephalitis.
The duration of uncomplicated influenza is 1-7 days. Prognosis is excellent. Most fatalities are due to secondary bacterial pneumonia.
Enteroviral pharyngitis is usually benign and self-limited.
Patient education should emphasize the natural course of viral infection and that it takes several days to feel better. Patients must understand that antibiotics are not needed for sore throats of viral origin. Risk of allergic reactions, fungal superinfection, and bacterial resistance should be discussed.
Patients should be reassured that certain measures, including pain relievers, throat sprays or lozenges, and gargling with warm salt water, improve symptoms without antibiotics. It is often challenging to reassure that antibiotic therapy is unnecessary.
Fever persisting for more than 5 days, extreme throat pain causing dysphagia, inability to open the mouth wide, or fainting spells when standing should prompt a visit to a doctor.
For excellent patient education resources, visit eMedicineHealth's Cold and Flu Center, Infections Center, and Ear, Nose, and Throat Center. Also, see eMedicineHealth's patient education articles Colds, Sore Throat, Mononucleosis, and Tonsillitis.
Perkins A. An approach to diagnosing the acute sore throat. Am Fam Physician. 1997 Jan. 55(1):131-8, 141-2. [Medline].
Bisno AL. Acute pharyngitis. N Engl J Med. 2001 Jan 18. 344(3):205-11. [Medline].
Weckx LL, Ruiz JE, Duperly J, et al. Efficacy of celecoxib in treating symptoms of viral pharyngitis: a double-blind, randomized study of celecoxib versus diclofenac. J Int Med Res. 2002 Mar-Apr. 30(2):185-94. [Medline].
Graham A, Fahey T. Evidence based case report. Sore throat: diagnostic and therapeutic dilemmas. BMJ. 1999 Jul 17. 319(7203):173-4. [Medline].
Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011 Jan 21. 60(1):1-24. [Medline].
Keyser LA, Karl M, Nafziger AN, Bertino JS Jr. Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients. Arch Intern Med. 2000 May 22. 160(10):1485-8. [Medline].
Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014 Apr 10. 4:CD008965. [Medline].
CDC. Seansonal Flu Weekly Report. Available at http://www.cdc.gov/flu/weekly/index.htm. Accessed: July 29, 2011.
WHO. Infleunza Update. Available at http://www.who.int/csr/disease/influenza/latest_update_GIP_surveillance/en/. Accessed: July 29, 2011.
Cingi C, Songu M, Ural A, Yildirim M, Erdogmus N, Bal C. Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: a prospective, randomized, double-blind, placebo-controlled, multicenter study. Ear Nose Throat J. 2010 Nov. 89(11):546-9. [Medline].
Ebell MH, Smith MA, Barry HC, et al. The rational clinical examination. Does this patient have strep throat?. JAMA. 2000 Dec 13. 284(22):2912-8. [Medline].
Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ. 1997 Aug 9. 315(7104):350-2. [Medline].
McIsaac WJ, White D, Tannenbaum D, et al. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan 13. 158(1):75-83. [Medline].
Singh S, Dolan JG, Centor RM. Optimal management of adults with pharyngitis--a multi-criteria decision analysis. BMC Med Inform Decis Mak. 2006 Mar 13. 6:14. [Medline].
Cunha BA. Group A streptococcal pharyngitis. Emerg Med. 1990. 22:93-96.
Cunha BA. Group A streptococcal pharyngitis versus colonization. Intern Med. 1994. 15:18-19.
Cunha BA. The Sore Throat: Mycoplasma pneumoniae pharyngitis. Emerg Med. 1988. 20:245-252.
Gwaltney JM Jr, Bisno AL. Pharyngitis. Mandell GI, Bennett JE, Dolin R, eds. Mandell, Douglas & Bennett's Principles of Infectious Diseases. Churchill Livingstone; 2000. Vol 1: 656-62.
Huovinen P, Lahtonen R, Ziegler T, et al. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med. 1989 Apr 15. 110(8):612-6. [Medline].
McIsaac WJ, Goel V, Slaughter PM. Reconsidering sore throats. Part 2: Alternative approach and practical office tool. Can Fam Physician. 1997 Mar. 43:495-500. [Medline].
McIsaac WJ, Goel V, Slaughter PM, et al. Reconsidering sore throats. Part I: Problems with current clinical practice. Can Fam Physician. 1997 Mar. 43:485-93. [Medline].
Paradise JL. Etiology and management of pharyngitis and pharyngotonsillitis in children: a current review. Ann Otol Rhinol Laryngol Suppl. 1992 Jan. 155:51-7. [Medline].
Pichichero ME. Sore throat after sore throat after sore throat. Are you asking the critical questions?. Postgrad Med. 1997 Jan. 101(1):205-6, 209-12, 215-8, passim. [Medline].
Wolter JM. Management of a sore throat. Antibiotics are no longer appropriate. Aust Fam Physician. 1998 Apr. 27(4):279-81. [Medline].
Yoda K, Sata T, Kurata T, et al. Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. Arch Otolaryngol Head Neck Surg. 2000 Feb. 126(2):185-93. [Medline].